You are here

The Psoriasis PACT Faculty

Meet The Psoriasis PACT Faculty

This multidisciplinary panel of psoriasis experts from around the world comprises a diverse group of dermatologists, other physician specialties, allied health care professionals, and patient advocates. Each member of The Psoriasis PACT faculty brings experience, leadership skills, and a unique perspective to this diverse group. Their goal is to share their knowledge with each other, and then with you, to elevate the standard of care and quality of life for patients with psoriasis.

Alan Menter

Alan Menter, MD

Chairman, The Psoriasis PACT

Alan Menter, MD (Chairman)

Dr Menter was appointed chairman of the Division of Dermatology at Baylor University Medical Center, Dallas, Texas, USA, in 1992 and still holds that position. In 2007, he was appointed director of the Baylor Research Center and, in 2010, program director of the newly formed Dermatology Residency Program at Baylor University Medical Center.

In 1994, he coauthored the first gene discovery for psoriasis, published in Science. His research on psoriasis has examined everything from ultraviolet phototherapy and biologic therapy to the mapping of genetic patterns to predict if a person is at risk for developing psoriasis. In 2004, Dr Menter helped found the International Psoriasis Council to raise international awareness of psoriasis as a serious autoimmune disease that can significantly affect quality of life. His clinical practice includes more than 1600 patients on systemic and biologic therapy and phototherapy.

Dr Menter has published more than 300 articles, 4 books, and 19 book chapters. He serves as a member of the editorial board for several medical journals, including the Journal of Clinical Dermatology and Clinical and Experimental Dermatology.

Luna Azulay

Luna Azulay-Abulafia, PhD

Luna Azulay-Abulafia, PhD

Dr Azulay-Abulafia has a doctorate in dermatology, and is a professor of dermatology at Universidade do Estado do Rio de Janeiro, Universidade Gama Filho, Instituto de Dermatologia Prof R D Azulay. She is the author of the chapter “Immunobiologics in Psoriasis” in the Brazilian Consensus of Psoriasis, 2nd edition, and has edited 3 books:


  • Azulay Dermatologia (Text Book)) Editora Gen/Guanabara Koogan 6th Edition
  • Atlas de Dermatologia da Semiologia ao diagnostico Editora Elsevier 2nd Edition 2013
  • Dermatologia e Gravidez (Dermatology and Pregnancy) 1st edition Editora Elsevier


Christopher Griffiths

Christopher Griffiths, MD

Christopher Griffiths, MD

Dr Chris Griffiths was appointed to the Foundation Chair in Dermatology at the University of Manchester, United Kingdom, in 1994, and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. Professor Griffiths, with his colleague Robert Chalmers, introduced a multidisciplinary clinic for severe psoriasis—the Manchester Psoriasis Service—awarded Hospital Doctor Dermatology Team of the Year in 2002.

Professor Griffiths’ named lectureships include Sydney Watson Smith (2006); Parkes Weber (2007); Von Zumbusch, Munich (2008); and Hellerstrom, Stockholm (2010). The Times named him as one of the United Kingdom’s Top 200 doctors in 2010, and in 2011, he was appointed as a National Institute for Health Research Senior Investigator and elected to the Fellowship of the Academy of Medical Sciences.

He serves on the editorial boards of eight scientific journals. He has published 466 PubMed-cited articles, has an h-Index of 74, and is lead editor of Rook’s Textbook of Dermatology. Professor Griffiths has long-standing research interests in all aspects of psoriasis including immunological mechanisms, immunotherapy, pharmacogenomics, and the ‘brain–skin axis.’

Alexa Kimball

Alexa Kimball, MD, MPH

Alexa Kimball, MD, MPH

Dr Alexa Boer Kimball is a professor of dermatology at Harvard Medical School, Boston, MA, USA. She also serves as the director of the Clinical Unit for Research Trials and Outcomes in Skin based at the Massachusetts General Hospital in Boston. She is widely recognized for her work on psoriasis, physician workforce economics, clinical trials, and outcomes research, and has published articles in journals such as Archives of Dermatology, Arthritis & Rheumatism, British Journal of Dermatology, Journal of the American Academy of Dermatology, The Lancet, and Journal of the American Medical Association Dr Kimball was previously associate editor for the Clinical Trials and Therapeutics section of the Journal of the American Academy of Dermatology and a medical editor for the Dermatology section of eMedicine. She is also the author of the book 101 Questions and Answers About Psoriasis, which has been translated into Spanish, Greek, and Korean.

Yoshinori Umezawa

Yoshinori Umezawa, MD

Yoshinori Umezawa, MD

Since 2011, Dr Umezawa has been an assistant professor in the Department of Dermatology at the Jikei University School of Medicine in Tokyo, Japan. For the previous 4 years, he was a clinical research fellow at the St John’s Institute of Dermatology, Kings College, London. Dr Umezawa has also held assistant and associate professorships in the Department of Dermatology at the School of Medicine, Tokai University, Kanagawa. He received his Doctor of Medicine degree from Tokyo Medical University.

Over the last 10 years, Dr Umezawa has conducted a wide variety of research related to psoriasis and its treatment, and has published more than 30 articles in international, peer-reviewed journals.

Dr Umezawa belongs to multiple professional societies, including the Japanese Dermatological Association and the Japanese Society for Psoriasis Research. He is a councilor for the Japanese Society for Dermatological Surgery.

April S. Abernethy, ND

April Abernethy, ND

April Abernethy, ND

Dr April Abernethy is associate director of Medical Programs at the National Psoriasis Foundation, Portland, OR, USA.

Dr Abernethy is an active member of a number of national and international professional societies and committees including the Dermatology Nurses’ Association, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and the National Psoriasis Foundation. She serves on the board of directors and is cofounder of the International Dermatology Outcomes Measures. She is managing editor of Psoriasis Forum.

Dr Abernethy has received numerous honors and recognition for her work, including the Outstanding Leadership Award and Presidential Ambassador in Recognition of Leadership from the National College of Natural Medicine, Portland. She has given a number of interviews, presentations, and invited lectures on her research. In 2012,
Dr Abernethy was elected to be committee chair of the American Cancer Society, Relay for Life event in Tualatin, OR.


April Armstrong, MD, MPH

April Armstrong, MD, MPH

April Armstrong, MD, MPH, is associate dean of Clinical Research at the University of Southern California in Los Angeles. She also serves as director of Clinical Research for the Southern California Clinical and Translational Research Institute (SC CTSI). In the Department of Dermatology at USC, she serves as Vice Chair, Director of Clinical Trials and Outcomes Research, and director of the Psoriasis Program.

Dr Armstrong obtained her medical degree from Harvard Medical School in Boston, Massachusetts and completed dermatology residency at the Harvard Dermatology Residency Program. She also obtained a master of Public Health degree from Harvard School of Public Health. Prior to joining the faculty at the University of Southern California, she was vice chair and director of Psoriasis Programs at the University of California Davis and later at the University of Colorado in Denver.

Dr Armstrong believes that good clinical practice needs to be rooted in evidence-based medicine. Dr Armstrong’s clinical expertise lies in inflammatory skin diseases. She is dedicated to providing the highest quality of care for patients with psoriasis and to making the latest treatment options available to them.

In her own research, Dr Armstrong is particularly interested in the appropriate use of systemic agents, comparative effectiveness research, and psoriasis comorbidities. Dr Armstrong has conducted studies examining how new therapies affect patients’ disease states, quality of life, and their access to medical care. She is a federally funded investigator with extensive clinical trial experience, having led or collaborated on more than 120 studies. She authored more than 150 peer-reviewed scientific publications and has been an editor for the top pharmacology textbook Principles of Pharmacology. Her work has been supported by the National Institutes of Health, Patient-Centered Outcomes Research Institute, the Agency for Healthcare Research and Quality, the Dermatology Foundation, and the National Psoriasis Foundation.

Dr Armstrong has held multiple leadership positions at professional societies, serving on the Medical Board of the National Psoriasis Foundation, counselor to the International Psoriasis Council, Steering Committee Member for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. She is chair for Teledermatology SIG at the American Telemedicine Association. She has served on multiple task forces and committees at the American Academy of Dermatology. Dr Armstrong also served on the editorial boards of JAMA Dermatology, Journal of the American Academy of Dermatology, and Telemedicine and e-Health. She was also past president of Sacramento Valley Dermatologic Society.


Ehrin J. Armstrong, MD, MSc

 Ehrin J. Armstrong, MD, MSc

Dr Ehrin J. Armstrong is an associate professor at the University of Colorado Denver VA Medical Center in Denver, CO, USA, where he is Director of Interventional Cardiology and Co-Director of the Vascular Laboratory. After graduating magna cum laude from Harvard Medical School in Boston, MA, Dr Armstrong completed an internal medicine residency at Massachusetts General Hospital in Boston and a cardiology fellowship at the University of California, San Francisco, in San Francisco, CA. Dr Armstrong’s research focus is to understand the relationship of inflammation to the onset of atherosclerosis and coronary artery disease. He maintains a translational research laboratory and has published extensively on endothelial biology and endothelial-monocyte interactions, with publications in the Journal of the American College of Cardiology, Circulation, and Proceedings of the National Academy of Sciences. His research related to psoriasis includes the first study describing an association between psoriasis and angiographically-confirmed coronary artery disease, as well as a recent meta-analysis of the association between psoriasis and major adverse cardiovascular events.

Joel Gelfand, MD, MSCE

Dr Joel Gelfand is associate professor of Dermatology and Epidemiology (tenured), and senior scholar, at the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. He is a board-certified dermatologist whose clinical work focuses on general dermatology and psoriasis.

Dr Gelfand’s original research articles have appeared in the Journal of the American Medical Association, British Medical Journal, European Heart Journal, Journal of Investigative Dermatology, Annals of Rheumatic Disease, Archives of Dermatology, British Journal of Dermatology, and Journal of the American Academy of Dermatology (JAAD). He is the author of more than 100 research articles, reviews, and book chapters, which have been cited more than 6000 times. He is an associate editor for Pharmacoepidemiology and Drug Safety, a member of the editorial board for the JAAD, and an editor for Continuing Medical Education.

He is a member of the American Academy of Dermatology, the Society for Investigative Dermatology, and the International Society for Pharmacoepidemiology. In 2011, he was the recipient of the prestigious American Skin Association Achievement Award for Psoriasis Research and the Perelman School of Medicine’s Marjorie Bowman Award for Clinical Research Excellence. In 2013, he was elected to the American Society for Clinical Investigation.


Paolo Gisondi, MD

Paolo Gisondi, MD

Dr Paolo Gisondi currently works as assistant professor in the Dermatology and Venereology Section of the University Hospital of Verona, Italy. He received his degree in medicine from the Catholic University of Rome in 1997, and then specialized in dermatology and venereology at the University of Parma in 2002. He is a member of the Italian Society of Dermatology, European Academy of Dermatology and Venereology, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and he has been invited to join the European Dermato-Epidemiology Network.

Dr Gisondi is an editorial board member of The Open Dermatology Journal, World Journal of Diabetes, and Advances in Psoriasis and Inflammatory Skin Diseases. He has been subinvestigator in 15 clinical phase 3 randomized trials investigating the effects of biological therapies in psoriasis. His main scientific interests include the epidemiological, clinical (ie, comorbidities), and therapeutic aspects of psoriasis and psoriatic arthritis. Apart from clinical research, more than half his working hours are dedicated to the outpatient clinic and dermatological surgery. He is a coauthor of
105 original articles, 14 book chapters, 131 abstracts for congresses, and 155 invited lectures.


Wayne Gulliver, MD

Wayne Gulliver, MD

Dr Wayne Gulliver is professor of medicine and dermatology at the Memorial University of Newfoundland, St John’s, Canada. Dr Gulliver is an experienced educator, clinician, researcher, and administrator. His research interests include psoriasis, comorbidities, and genetics, and he has conducted more than 200 dermatology clinical trials.

Dr Gulliver is a former chair of medicine at the Memorial University of Newfoundland and past member of the Governing Council of the National Research Council. He also holds adjunct professorships to Henan University of Traditional Chinese Medicine and Zhengzhou University, in Zhengzhou, Henan, China.


Philip Helliwell, MD,

Philip Helliwell, MD, MSCE

Dr Philip Helliwell is currently senior lecturer in rheumatology at the University of Leeds, United Kingdom, and Honorary Consultant Rheumatologist for the Bradford Hospitals NHS Trust.

He is a member of the Assessment of SpondyloArthritis International Society and cofounder and vice president of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He has worked with GRAPPA in developing single and composite outcome measures in psoriatic arthritis and has just recruited the first treat-to-target study in early psoriatic arthritis.

Dr Helliwell is cofounder and coleader for the Bradford (University) Diploma in Rheumatology and Musculoskeletal Medicine and is an active member of the Bradford and Airedale Musculoskeletal Alliance, a tier-2 service provided to general practitioners in the designated geographical area.

Current and past research includes treatment paradigms, clinical features, and classification of psoriatic arthritis; treatment paradigms in psoriatic arthritis; biomechanics of joints, gait assessment, and foot disorders in inflammatory and noninflammatory arthritis, epidemiology of rheumatic disease and community-based studies of psoriasis, and psoriatic arthritis.


Lluís Puig, MD, PhD

Lluís Puig, MD, PhD

Dr Lluís Puig is director of the Department of Dermatology, Hospital de la Santa Creui Sant Pau and professor of dermatology at the Universitat Autònoma de Barcelona Medical School, Barcelona, Spain.

In the last 10 years, Dr Puig has focused on clinical research in the treatment of psoriasis with biological agents, an area in which he is considered to be a key opinion leader both nationally and internationally, having taught at numerous national and international conferences, workshops, and seminars. The results of his research have been published in numerous articles, 121 book chapters, and
11 international book chapters. He has participated in 21 clinical trials to date, in most cases, acting as principal investigator.

Dr Puig is a member of the Spanish Academy of Dermatology and Venereology and founding member of several of its working groups, and current coordinator of the Spanish Psoriasis Group. He is an aggregate member of the Spanish Society of Rheumatology and its Grupo Español de Estudio para la Artritis Psoriásica and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. He is a member of several international societies, including the European Academy of Dermatology and Venereology, American Academy of Dermatology, Colegio Ibero-Latino-Americano de Dermatología, European Society for Dermatology Research, American Society of Dermatopathology, International Society of Dermatopathology, scientific advisor to the Psoriasis International Network, and member of the International Psoriasis Council.


Abrar Qureshi, MD, MPH

Abrar Qureshi, MD, MPH

Dr Abrar Qureshi is associate professor of dermatology at Brigham and Women's Hospital (BWH), Harvard Medical School, Boston, MA, USA, and associate epidemiologist at the Channing Laboratory at BWH. He runs a combined dermatology and rheumatology clinic at BWH, and has been managing patients with psoriasis and psoriatic arthritis along with his rheumatology colleagues since 2003. He has a special interest in issues at the interface of dermatology and rheumatology and has published several scientific manuscripts on the epidemiology of psoriasis and psoriatic arthritis.


Lakshi Aldredge,

Lakshi Aldredge,

Ms Lakshi Aldredge is an adult nurse practitioner who practices at the Portland VA Medical Center, Portland, OR, USA, in Dermatology Service as one of the lead nurse practitioners for the hospital. She obtained her master of science in nursing degree from the University of Portland in 1998, and holds a national certification as an adult nurse practitioner through the American Nurses Credentialing Center. She is immediate past chair of the Nurse Practitioner Society of the Dermatology Nurses’ Association and a past president of the DNA as well. She is a member of the medical advisory board of the National Psoriasis Foundation and serves on the editorial advisory board for Dermatology World, is associate editor for Psoriasis Forum, and is a member of the editorial board of the Journal of the Dermatology Nurses' Association. She has given numerous lectures addressing the needs of psoriasis patients to patients, providers, and health care workers in many specialties. She received the VA’s Nursing Excellence Award in 2008.

Christine Bundy

Christine Bundy, PhD,
CPsychol, AFBPS

Senior Lecturer in
Behavioural Medicine

Manchester Academic
Health Science Centre

University of Manchester
Manchester, UK

Consultant Psychologist (Hon)
Salford Royal NHS Foundation Trust
Salford, UK

Christine Bundy, PhD, CPsychol, AFBPS

Christine Bundy, PhD, CPsychol, AFBPS, is currently Senior Lecturer in Behavioural Medicine at the University of Manchester’s Manchester Academic Health Science Centre, in the UK. She is also an (Honorary) Consultant Psychologist at the Salford Royal NHS Foundation Trust in Salford, UK. She received her doctorate in psychology from the University of Birmingham in Birmingham, UK. Dr Bundy has conducted translational research, applying psychology to inform and improve patient care. Her emphasis is on the role of beliefs about long-term conditions and the impact on mood and health behavior. Over the past 7 years, she has focused on psoriasis. Dr Bundy is president-elect of the UK Society for Behavioural Medicine and she has served on 2 NICE clinical guideline development groups. She has authored more than 65 peer-reviewed publications including 4 key reports on the development of NHS patient services, and she leads or collaborates on National Institute for Health Research, industry, and patient charity research awards.

>Chris Baker

Chris Baker, MBBS, FACD

Director, Department of

St. Vincent’s Hospital
Clinical Associate Professor

University of Melbourne
Melbourne, Australia

Chris Baker, MBBS, FACD

Professor Baker is director of the Department of Dermatology at St Vincent’s Hospital Melbourne, clinical associate professor at the University of Melbourne and past president of the Skin and Cancer Foundation Inc.
Professor Baker is a consultant dermatologist and fellow of the Australasian College of Dermatologists, working in a public hospital and private practice. He has academic and research interests in advanced psoriasis therapies and photosensitivity disorders. He has also been an investigator on numerous clinical trials ranging from biological therapies for psoriasis to alpha MSH analogs.
Professor Baker is co-founder of the Australasian Psoriasis Registry, an Australian and New Zealand registry established in 2008 for psoriasis patients on systemic and biologic therapies with more than 1200 patients recorded. His published interests include treatment algorithms for psoriasis and impact of psoriasis on quality of life.

Courtney Schneider

Courtney Schneider is Director of Strategic Alliances for the National Psoriasis Foundation headquartered in Portland, Oregon. She oversees $6.5 million in national corporate partnerships for the Foundation. Prior to her joining the Foundation in 2012, she has had more than ten years’ experience in the nonprofit sector focusing on fund and event development in health and international organizations. In her role, Ms. Schneider has presented internationally on the impact of psoriatic disease and the patient’s perspective and role in research and clinical outcomes. She completed her Bachelor of Arts in political science and history from Emory University and has been diagnosed with psoriasis since the age of 11.

Hervé Bachelez

Hervé Bachelez, MD, PhD

Professor, Department of Dermatology
Saint-Louis University Hospital

Paris, France

Hervé Bachelez, MD, PhD

Professor Bachelez is professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France, and head of the Inflammatory Skin Diseases Unit of the dermatology department. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the University of Paris 7, where he received his PhD in immunology in 1999. Professor Bachelez’s clinical and scientific research focuses on immunogenetics of inflammatory skin diseases at the Institut National de la Santé et de la Recherche Médicale (INSERM) at the Imagine Institute in Necker Hospital. His areas of scientific interest include psoriasis and other immune-mediated and inflammatory skin diseases, from bench to bedside. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Society for Dermatological Research (ESDR), the European Dermatology Forum (EDF). He is past president of the French Society for Dermatological Research, has been a board member of the French Society for Dermatology and is past president of its psoriasis group, and is the current secretary of the International Psoriasis Council. Professor Bachelez has published more than 160 manuscripts in peer-reviewed journals, including the New England Journal of Medicine, The Lancet, Journal of Clinical Investigation, and Arthritis and Rheumatism as leading author.



We would like to know more about how you are managing your patients with moderate to severe psoriasis. Answer our quick poll question, and see instantly how your colleagues have responded!
The Psoriasis PACT Poll